SGHERZA, N. et al. 2022. Prospective, case-control study of serological response after two doses of BNT162b2 anti-SARS-CoV-2 mRNA vaccine in transfusion-dependent thalassemic patients. Mediterranean Journal of Hematology and Infectious Diseases. 14, 1 (Jun. 2022), e2022056. DOI:https://doi.org/10.4084/MJHID.2022.056.